Tendyne™ TMVI

QUALITY TIME
SECURED

.

DISTINCT DESIGN OF TENDYNE™ TMVI ENABLES DEVICE CONTROL

A breakthrough TECHNOLOGY DESIGNED TO ELIMINATE MITRAL REGURGITATION

  • Designed with the unique challenges of the mitral anatomy in mind
  • Beating heart procedure—no requirement for cardiopulmonary bypass or rapid pacing

Valve

Dual-frame design with ability to customize fit to individual patient anatomies

Inner frame

Self-expanding. tri-leaflet, bioprosthetic valve

Outer frame

Contoured design supports a secure seal over native anatomy

3D FLEXIBILITY. INFINITE POSSIBILITY

Anchoring system

Tether and pad

REACH A BROAD RANGE OF PATIENTS WITH FLEXIBLE DESIGN AND SIZING

The distinct design enables safe and effective treatment for a broad range of patients.

  • Contoured, dual-frame design conforms to mitral annulus for sealing and securement
  • Low risk for paravalvular leak1
  • Two valve profiles available to reduce risk of left ventricular outflow tract (LVOT) obstruction
  • A wide range of annular dimensions due to array of valve sizes


IMPLANT WITH CONFIDENCE

  • Controlled and predictable procedure
  • Supported procedural planning
  • Fully retrievable intraprocedurally and repositionable for optimal valve placement

MAT-2000613 v4.0 | Item approved for Global OUS use only.

References
  1. Muller, D. Two-Year Outcomes of Tendyne Transcatheter Mitral Valve Implantation to Treat Symptomatic, Severe Mitral Regurgitation. David Muller. Presented at: PCR E-Course, June, 2020.
  2. Abbott Medical Internal Document. Expanded Clinical Study of Tendyne Mitral Valve System “CE Study” Clinical Study Report. Study Document No: CL1010682.

This site uses cookies to improve your experience.

To find out more please read our Privacy and Cookies policy.

Ok

Sign up

Receive updates from Abbott Structural Heart

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

YOU ARE ABOUT TO LEAVE
www.structural­heart­solutions.com

You are now leaving www.structuralheartsolutions.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.